Letters to the Editor
Vol. 3 No. 3 (2024)
The intriguing association between cancer and congenital bleeding disorders
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Received: 9 July 2024
Accepted: 4 November 2024
Accepted: 4 November 2024
565
Views
133
Downloads
Authors
The relationship between congenital bleeding disorders and cancer is complex and multifactorial....
Downloads
Download data is not yet available.
Citations
1. Liu CJ, Yu YB, Teng CJ, et al. Increased cancer risk in patients with haemophilia A: a nationwide population-based 14-year study in Taiwan. Haemophilia 2014;20:741–6. DOI: https://doi.org/10.1111/hae.12450
2. Colonne CK, Favaloro EJ, Pasalic L. The intriguing connections between von Willebrand factor, ADAMTS13 and cancer. Healthcare (Basel) 2022;10:557. DOI: https://doi.org/10.3390/healthcare10030557
3. Franchini M, Di Perna C, Santoro C, et al. Cancers in patients with von Willebrand disease: a survey from the Italian Association of Haemophilia Centres. Semin Thromb Hemost 2016;42:36–41. DOI: https://doi.org/10.1055/s-0035-1564844
4. Darby SC, Kan SW, Spooner RJ, et al. Mortality rates, life expectancy, and causes of death in people with hemophilia A or B in the United Kingdom who were not infected with HIV. Blood 2007;110:815–25. DOI: https://doi.org/10.1182/blood-2006-10-050435
5. Tagliaferri A, Di Perna C, Santoro C, et al. Cancers in patients with hemophilia: a retrospective study from the Italian Association of Hemophilia Centers. J Thromb Haemost 2012;10:90–5. DOI: https://doi.org/10.1111/j.1538-7836.2011.04566.x
6. Shetty S, Sharma N, Ghosh K. Epidemiology of hepatocellular carcinoma (HCC) in hemophilia. Crit Rev Oncol Hematol 2016;99:129–33. DOI: https://doi.org/10.1016/j.critrevonc.2015.12.009
7. Zanon E, Porreca A, Simioni P. Haemophilia and cancer: a literature review. J Clin Med 2024;19;13:1770. DOI: https://doi.org/10.3390/jcm13061770
8. Lee CA. The natural history of HIV disease in haemophilia. Blood Rev 1998;12:135–44. DOI: https://doi.org/10.1016/S0268-960X(98)90011-X
9. Franchini M, Tagliaferri A, Rossetti G, et al. The Natural History of Hepatitis C Virus Infection in Hemophiliacs. Hematology 2001;6:135–42. DOI: https://doi.org/10.1080/10245332.2001.11746564
10. Franchini M. Haemophilia and cancer: a personal perspective. Blood Transfus 2013;11:26-31.
11. Ragni MV, Belle SH, Jaffe RA, et al. Acquired immunodeficiency syndrome-associated non-Hodgkin’s lymphomas and other malignancies in patients with hemophilia. Blood 1993;81:1889–97. DOI: https://doi.org/10.1182/blood.V81.7.1889.1889
12. Darby SC, Ewart DW, Giangrande PL, et al. Mortality from liver cancer and liver disease in haemophilic men and boys in UK given blood products contaminated with hepatitis C. Lancet 1997;350:1425–31. DOI: https://doi.org/10.1016/S0140-6736(97)05413-5
13. Miesbach W, Seifried E. Does haemophilia influence cancer‐related mortality in HIV‐negative patients? Haemophilia 2010;17:55–60. DOI: https://doi.org/10.1111/j.1365-2516.2010.02364.x
14. Colombo M, de Franchis R, Del Ninno E, et al. Hepatocellular carcinoma in Italian patients with cirrhosis. N Engl J Med 1991;325:675–80. DOI: https://doi.org/10.1056/NEJM199109053251002
15. Altekruse SF, Henley SJ, Cucinelli JE, et al. Changing hepatocellular carcinoma incidence and liver cancer mortality rates in the United States. Am J Gastroenterol 2014;109:542–53. DOI: https://doi.org/10.1038/ajg.2014.11
16. Huang YC, Tsan YT, Chan WC, et al. Incidence and survival of cancers among 1,054 hemophilia patients: a nationwide and 14-year cohort study. Am J Hematol 2015;90. DOI: https://doi.org/10.1002/ajh.23947
17. Hassan S, Monahan RC, Mauser-Bunschoten EP, et al. Mortality, life expectancy, and causes of death of persons with hemophilia in the Netherlands 2001–2018. J Thromb Haemost 2021;19:645–53. DOI: https://doi.org/10.1111/jth.15182
18. Plug I, Van Der Bom JG, Peters M, et al. Mortality and causes of death in patients with hemophilia, 1992–2001: a prospective cohort study. J Thromb Haemost 2006;4:510–6. DOI: https://doi.org/10.1111/j.1538-7836.2006.01808.x
19. Franchini M, Lippi G, Montagnana M, et al. Hemophilia and cancer: A new challenge for hemophilia centers. Cancer Treat Rev 2009;35:374–7. DOI: https://doi.org/10.1016/j.ctrv.2009.01.001
20. Tagalakis V, Tamim H, Blostein M, et al. Use of warfarin and risk of urogenital cancer: a population-based, nested case-control study. Lancet Oncol 2007;8:395–402. DOI: https://doi.org/10.1016/S1470-2045(07)70046-3
21. Kakkar AK, Levine MN, Kadziola Z, et al. Low molecular weight heparin, therapy with dalteparin, and survival in advanced cancer: the fragmin advanced malignancy outcome study (FAMOUS). J Clin Oncol 2004;22:1944–8. DOI: https://doi.org/10.1200/JCO.2004.10.002
22. Brüggemann LW, Versteeg HH, Niers TM, et al. Experimental melanoma metastasis in lungs of mice with congenital coagulation disorders. J Cell Mol Me 2008;12:2622–7. DOI: https://doi.org/10.1111/j.1582-4934.2008.00316.x
23. Langer F, Amirkhosravi A, Ingersoll SB, et al. Experimental metastasis and primary tumor growth in mice with hemophilia A. J Thromb Haemost 2006;4:1056–62. DOI: https://doi.org/10.1111/j.1538-7836.2006.01883.x
24. Dolan G. The challenge of an ageing haemophilic population. Haemophilia 2010;16:11–6. DOI: https://doi.org/10.1111/j.1365-2516.2010.02287.x
How to Cite
1.
Zanon E. The intriguing association between cancer and congenital bleeding disorders. Bleeding Thromb Vasc Biol [Internet]. 2024 Dec. 16 [cited 2026 Apr. 16];3(3). Available from: https://www.btvb.org/btvb/article/view/146
Copyright (c) 2024 The Author(s)
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Similar Articles
- PO47 | Hemophilia A and antithrombin deficiency: a case of natural hemostatic rebalancing , Bleeding, Thrombosis and Vascular Biology: Vol. 4 No. s1 (2025)
- Marco Cattaneo, Claudia Ghali, Mariangela Scavone, ReDIP, the Italian network for the diagnosis of congenital platelet function disorders , Bleeding, Thrombosis and Vascular Biology: Vol. 3 No. 1 (2024)
- Giovanni Di Minno, Gaia Spadarella, Ilenia Lorenza Calcaterra, Giancarlo Castaman, Paolo Simioni, Raimondo De Cristofaro, Cristina Santoro, Flora Peyvandi, Matteo Di Minno, The evolving landscape of gene therapy for congenital severe hemophilia: a 2024 state of the art , Bleeding, Thrombosis and Vascular Biology: Vol. 3 No. 2 (2024)
- Fabio Candura, Emanuela Marchesini, Gian Luca Forni, Alessandro Gringeri, Ilaria Gentilini, Mirko Tricoli, Osama Najjar, Luciana Teofili, Launch of a National Registry for Congenital Hematological Disorders in Palestine: the Haemo-PAL Initiative , Bleeding, Thrombosis and Vascular Biology: Vol. 5 No. 1 (2026)
- Società Italiana di Emostasi e Trombosi, PO34 | INVESTIGATORS’ DECISIONS ON ANTICOAGULATION AFTER EXTENDED API-CAT TREATMENT FOR CANCER VENOUS THROMBOEMBOLISM , Bleeding, Thrombosis and Vascular Biology: Vol. 5 No. s1 (2026)
- PO07 | Liver transplant in a case of congenital afibrinogenemia , Bleeding, Thrombosis and Vascular Biology: Vol. 4 No. s1 (2025)
- Cristina Santoro, Alessandro Casini, Addressing some challenges of congenital fibrinogen disorders in 2023 and beyond , Bleeding, Thrombosis and Vascular Biology: Vol. 2 No. 3 (2023)
- CO02 | Hepatic fibrosis as predictor of cancer-associated thrombosis in patients with intrahepatic cholangiocarcinoma , Bleeding, Thrombosis and Vascular Biology: Vol. 4 No. s1 (2025)
- CO32 | Major surgery in patients with severe hemophilia A without inhibitors receiving prophylaxis with fitusiran , Bleeding, Thrombosis and Vascular Biology: Vol. 4 No. s1 (2025)
- PO05 | Intensive FVIII replacement in haemophilia patients with hypertrophic synovium: a randomized study , Bleeding, Thrombosis and Vascular Biology: Vol. 4 No. s1 (2025)
You may also start an advanced similarity search for this article.
